How HIV clinical trials have fared

Simple item page
dc.contributor.authorEmodek, Jacqueline
dc.date.accessioned2026-06-12T13:39:59Z
dc.date.available2026-06-12T13:39:59Z
dc.date.issued2017-12-01
dc.descriptionNewspaper article
dc.description.abstractHIV prevention and treatment trials in Uganda started in the 1990s. The first trial was on the lowest effective dose of a drug called Zidovudine (AZT), which was the first antiretroviral therapy (ART) drug to be used in HIV treatment. The drug was initially used in the Western world to treat cancer before experts discovered it could also be used to treat HIV.
dc.identifier.citationEmodek, J. (2017). How HIV clinical trials have fared. New Vision.
dc.identifier.urihttps://bdears.busitema.ac.ug/handle/123456789/5485
dc.language.isoen
dc.publisherNew Vision
dc.titleHow HIV clinical trials have fared
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
NV by Jacqueline Dec.1.2017.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Faculty of Health Sciences